Xarelto Lawsuit Plaintiffs Claim Manufacturers Used Misleading Advertisements

June 22, 2016 – – TheProductLawyers.com details the rising public concern over the safety of the anticoagulant drug, Xarelto. Following its FDA approval in 2011, it is often used to treat patients suffering from deep vein thrombosis and pulmonary embolism. Physicians also prescribe it to individuals recovering from knee or hip surgery, in order to prevent the formation of clots and to those at risk for strokes. Its popularity largely stems from the fact that, unlike other blood thinners, it does not require extensive monitoring, changes in diet, or constant dosage adjustments.

However, problems with the drug became apparent. The FDA has issued two black box warnings to Xarelto. Barring outright recall, this is the most stringent corrective action at the avail of the agency. Patients have reported that if they did not slowly reduce their use of Xarelto and replace it with an alternative anticoagulant regimen, they frequently developed blood clots. In studies subsequent to its widespread use, patients shifting from another anticoagulant to Xarelto often bled from the stomach or the eyes.

More than 3,000 lawsuits have been brought against Janssen Pharmaceuticals and Bayer AG. The Philadelphia Court of Common Pleas has combined 550 suits into a mass tort program. On an even larger scale, the U.S. Judicial Panel for Multidistrict Litigation consolidated 2,800 suits to form MDL No. 2592. In common, the plaintiffs seek reparations from the drug companies based on alleged dishonest business practices that concealed the negative features of the drug. Plaintiffs aver that the companies promoted the positive features of the drug to doctors and the public.

Additionally, the members of MDL No. 2592 claim that the companies placed individuals at a heightened risk for sudden and catastrophic bleeding events, without providing necessary product information. Four bellwether trials have been set for early in 2017. Preparation for these trials spanned from December 2015 to January 2016. Any further developments in regards to these trials will be discussed during monthly status conferences.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010953